339 related articles for article (PubMed ID: 23902639)
1. Angiotensin receptor-binding protein ATRAP/Agtrap inhibits metabolic dysfunction with visceral obesity.
Maeda A; Tamura K; Wakui H; Dejima T; Ohsawa M; Azushima K; Kanaoka T; Uneda K; Matsuda M; Yamashita A; Miyazaki N; Yatsu K; Hirawa N; Toya Y; Umemura S
J Am Heart Assoc; 2013 Jul; 2(4):e000312. PubMed ID: 23902639
[TBL] [Abstract][Full Text] [Related]
2. Adipocyte-Specific Enhancement of Angiotensin II Type 1 Receptor-Associated Protein Ameliorates Diet-Induced Visceral Obesity and Insulin Resistance.
Azushima K; Ohki K; Wakui H; Uneda K; Haku S; Kobayashi R; Haruhara K; Kinguchi S; Matsuda M; Maeda A; Toya Y; Yamashita A; Umemura S; Tamura K
J Am Heart Assoc; 2017 Mar; 6(3):. PubMed ID: 28264860
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin II type 1 receptor-associated protein in immune cells: a possible key factor in the pathogenesis of visceral obesity.
Tsukamoto S; Suzuki T; Wakui H; Uehara T; Ichikawa J; Okuda H; Haruhara K; Azushima K; Abe E; Tanaka S; Taguchi S; Hirota K; Kinguchi S; Yamashita A; Tamura T; Tamura K
Metabolism; 2023 Dec; 149():155706. PubMed ID: 37856903
[TBL] [Abstract][Full Text] [Related]
4. Renal tubule angiotensin II type 1 receptor-associated protein promotes natriuresis and inhibits salt-sensitive blood pressure elevation.
Wakui H; Uneda K; Tamura K; Ohsawa M; Azushima K; Kobayashi R; Ohki K; Dejima T; Kanaoka T; Tsurumi-Ikeya Y; Matsuda M; Haruhara K; Nishiyama A; Yabana M; Fujikawa T; Yamashita A; Umemura S
J Am Heart Assoc; 2015 Mar; 4(3):e001594. PubMed ID: 25792129
[TBL] [Abstract][Full Text] [Related]
5. ATRAP Expression in Brown Adipose Tissue Does Not Influence the Development of Diet-Induced Metabolic Disorders in Mice.
Ohki K; Wakui H; Azushima K; Uneda K; Haku S; Kobayashi R; Haruhara K; Kinguchi S; Matsuda M; Ohsawa M; Maeda A; Minegishi S; Ishigami T; Toya Y; Yamashita A; Umemura S; Tamura K
Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28335584
[TBL] [Abstract][Full Text] [Related]
6. Activation of angiotensin II type 1 receptor-associated protein exerts an inhibitory effect on vascular hypertrophy and oxidative stress in angiotensin II-mediated hypertension.
Wakui H; Dejima T; Tamura K; Uneda K; Azuma K; Maeda A; Ohsawa M; Kanaoka T; Azushima K; Kobayashi R; Matsuda M; Yamashita A; Umemura S
Cardiovasc Res; 2013 Dec; 100(3):511-9. PubMed ID: 24189624
[TBL] [Abstract][Full Text] [Related]
7. An angiotensin II type 1 receptor binding molecule has a critical role in hypertension in a chronic kidney disease model.
Kobayashi R; Wakui H; Azushima K; Uneda K; Haku S; Ohki K; Haruhara K; Kinguchi S; Matsuda M; Ohsawa M; Toya Y; Nishiyama A; Yamashita A; Tanabe K; Maeshima Y; Umemura S; Tamura K
Kidney Int; 2017 May; 91(5):1115-1125. PubMed ID: 28081856
[TBL] [Abstract][Full Text] [Related]
8. Enhanced angiotensin receptor-associated protein in renal tubule suppresses angiotensin-dependent hypertension.
Wakui H; Tamura K; Masuda S; Tsurumi-Ikeya Y; Fujita M; Maeda A; Ohsawa M; Azushima K; Uneda K; Matsuda M; Kitamura K; Uchida S; Toya Y; Kobori H; Nagahama K; Yamashita A; Umemura S
Hypertension; 2013 Jun; 61(6):1203-10. PubMed ID: 23529167
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II Type 1 Receptor-Associated Protein Regulates Kidney Aging and Lifespan Independent of Angiotensin.
Uneda K; Wakui H; Maeda A; Azushima K; Kobayashi R; Haku S; Ohki K; Haruhara K; Kinguchi S; Matsuda M; Ohsawa M; Minegishi S; Ishigami T; Toya Y; Atobe Y; Yamashita A; Umemura S; Tamura K
J Am Heart Assoc; 2017 Jul; 6(8):. PubMed ID: 28751545
[TBL] [Abstract][Full Text] [Related]
10. The pathophysiological role of angiotensin receptor-binding protein in hypertension and kidney diseases: Oshima Award Address 2019.
Wakui H
Clin Exp Nephrol; 2020 Apr; 24(4):289-294. PubMed ID: 32112267
[TBL] [Abstract][Full Text] [Related]
11. The physiology and pathophysiology of a novel angiotensin receptor-binding protein ATRAP/Agtrap.
Tamura K; Wakui H; Maeda A; Dejima T; Ohsawa M; Azushima K; Kanaoka T; Haku S; Uneda K; Masuda S; Azuma K; Shigenaga A; Koide Y; Tsurumi-Ikeya Y; Matsuda M; Toya Y; Tokita Y; Yamashita A; Umemura S
Curr Pharm Des; 2013; 19(17):3043-8. PubMed ID: 23176217
[TBL] [Abstract][Full Text] [Related]
12. Effects of ATRAP in Renal Proximal Tubules on Angiotensin-Dependent Hypertension.
Kinguchi S; Wakui H; Azushima K; Haruhara K; Koguchi T; Ohki K; Uneda K; Matsuda M; Haku S; Yamaji T; Yamada T; Kobayashi R; Minegishi S; Ishigami T; Yamashita A; Fujikawa T; Tamura K
J Am Heart Assoc; 2019 Apr; 8(8):e012395. PubMed ID: 30977419
[TBL] [Abstract][Full Text] [Related]
13. Adipose angiotensin II type 1 receptor-associated protein ameliorates metabolic disorders via promoting adipose tissue adipogenesis and browning.
Luo C; Lv N; Chang Z; Qu Q; Huang J
Eur J Cell Biol; 2017 Sep; 96(6):567-578. PubMed ID: 28539232
[TBL] [Abstract][Full Text] [Related]
14. Spred2 Regulates High Fat Diet-Induced Adipose Tissue Inflammation, and Metabolic Abnormalities in Mice.
Ohkura T; Yoshimura T; Fujisawa M; Ohara T; Marutani R; Usami K; Matsukawa A
Front Immunol; 2019; 10():17. PubMed ID: 30723473
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II Type 1 Receptor-associated Protein Inhibits Angiotensin II-induced Insulin Resistance with Suppression of Oxidative Stress in Skeletal Muscle Tissue.
Ohki K; Wakui H; Kishio N; Azushima K; Uneda K; Haku S; Kobayashi R; Haruhara K; Kinguchi S; Yamaji T; Yamada T; Minegishi S; Ishigami T; Toya Y; Yamashita A; Imajo K; Nakajima A; Kato I; Ohashi K; Tamura K
Sci Rep; 2018 Feb; 8(1):2846. PubMed ID: 29434287
[TBL] [Abstract][Full Text] [Related]
16. ATRAP, a receptor-interacting modulator of kidney physiology, as a novel player in blood pressure and beyond.
Tamura K; Azushima K; Kinguchi S; Wakui H; Yamaji T
Hypertens Res; 2022 Jan; 45(1):32-39. PubMed ID: 34642449
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II Type 1 Receptor Binding Molecule ATRAP as a Possible Modulator of Renal Sodium Handling and Blood Pressure in Pathophysiology.
Tamura K; Wakui H; Azushima K; Uneda K; Haku S; Kobayashi R; Ohki K; Haruhara K; Kinguchi S; Matsuda M; Yamashita A; Umemura S
Curr Med Chem; 2015; 22(28):3210-6. PubMed ID: 26295465
[TBL] [Abstract][Full Text] [Related]
18. Pathophysiology of human visceral obesity: an update.
Tchernof A; Després JP
Physiol Rev; 2013 Jan; 93(1):359-404. PubMed ID: 23303913
[TBL] [Abstract][Full Text] [Related]
19. TLR9 regulates adipose tissue inflammation and obesity-related metabolic disorders.
Hong CP; Yun CH; Lee GW; Park A; Kim YM; Jang MH
Obesity (Silver Spring); 2015 Nov; 23(11):2199-206. PubMed ID: 26260403
[TBL] [Abstract][Full Text] [Related]
20. Upstream stimulatory factors 1 and 2 mediate the transcription of angiotensin II binding and inhibitory protein.
Matsuda M; Tamura K; Wakui H; Maeda A; Ohsawa M; Kanaoka T; Azushima K; Uneda K; Haku S; Tsurumi-Ikeya Y; Toya Y; Maeshima Y; Yamashita A; Umemura S
J Biol Chem; 2013 Jun; 288(26):19238-49. PubMed ID: 23653383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
